PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer.

PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer. Gynecol Oncol. 2020 11; 159(2):322-328.

View in: PubMed

subject areas

Adenocarcinoma
Adenocarcinoma
Administration, Intravenous
Administration, Intravenous
Adult
Adult
Aged
Aged
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
B7-H1 Antigen
B7-H1 Antigen
Biomarkers, Tumor
Biomarkers, Tumor
Carcinoma, Squamous Cell
Carcinoma, Squamous Cell
Female
Female
Humans
Humans
Middle Aged
Middle Aged
Uterine Cervical Neoplasms
Uterine Cervical Neoplasms

authors with profiles

Kathleen Moore